Two novel pre-operative CRT regimens for resectable oesophageal cancer are to be compared and no control group is to be used. Here the sample size calculations based on the least favorable configuration are presented.
Appendix 1
Sample size calculation under least favorable configuration Thomas Jaki Two novel pre-operative CRT regimens for resectable oesophageal cancer are to be compared and no control group is to be used. Here the sample size calculations based on the least favorable configuration are presented.
Denote the number of patients responding on CRT 1 and 2 by S 1 and S 2 respectively and write the probability of a response on each treatment as p i , i = 1, 2. Then S i ∼ Bin(n, p i ). The least favorable configuration is use to set the power requirement in trials comparing multiple treatments arms. It specifies the power such that one of the treatments (treatment 1, say) achieves the interesting effect size p, whilst the other treatments achieve an effect size of p 0 . In other words the most promising treatment is just at the clinically relevant level while the others are as good as they can be without being of further interest. This specification implies that the power will be larger then the prespecified level if more than 1 treatment do have a clinically relevant effect.
Setting the clinically relevant effect to 0.35 and the not interesting effect at 0.15, we want P (take any treatment to Phase III|p 1 = p 2 = 0.15) = P (max(S 1 , S 2 ) > k|p 1 = p 2 = 0.15) ≤ α and P (take any treatment to Phase III|p 1 = p 2 = 0.35) = P (S 1 > k and S 1 ≥ S 2 |p 1 = 0.35, p 2 = 0.15
Using similar arguments we find
Using the above distribution we can then solve the two equations above for n and k using R (code below).
For α = 0.1 and 1 − β = 0.8 we find n = 28 and k = 7 while n = 38 and k = 9 is found for 1 − β = 0.9. The 
